Artikel ; Online: Impact of acyclovir use on survival of patients with ventilator-associated pneumonia and high load herpes simplex virus replication.
Critical care (London, England)
2020 Band 24, Heft 1, Seite(n) 12
Abstract: Background: Herpes simplex virus (HSV) replication can be detected in the respiratory secretions of a high proportion of ventilated intensive care unit (ICU) patients. However, the clinical significance remains poorly defined. We investigated whether ... ...
Abstract | Background: Herpes simplex virus (HSV) replication can be detected in the respiratory secretions of a high proportion of ventilated intensive care unit (ICU) patients. However, the clinical significance remains poorly defined. We investigated whether patients with ventilator-associated pneumonia not responding to antibiotics and in whom high levels of HSV could be detected in respiratory secretions benefit from acyclovir treatment. Methods: Respiratory secretions (bronchoalveolar lavage fluid or tracheal aspirates) were tested for HSV replication by quantitative real-time PCR. ICU survival times, clinical parameters, and radiographic findings were retrospectively compared between untreated and acyclovir treated patients with high (> 10 Results: Fifty-seven low and 69 high viral load patients were identified. Fewer patients with high viral load responded to antibiotic treatment (12% compared to 40% of low load patients, p = 0.001). Acyclovir improved median ICU survival (8 vs 22 days, p = 0.014) and was associated with a significantly reduced hazard ratio for ICU death (HR = 0.31, 95% CI 0.11-0.92, p = 0.035) in high load patients only. Moreover, circulatory and pulmonary oxygenation function of high load patients improved significantly over the course of acyclovir treatment: mean norepinephrine doses decreased from 0.05 to 0.02 μg/kg body weight/min between days 0 and 6 of treatment (p = 0.049), and median PaO Conclusions: In patients with ventilator-associated pneumonia, antibiotic treatment failure, and high levels of HSV replication, acyclovir treatment was associated with a significantly longer time to death in the ICU and improved circulatory and pulmonary function. This suggests a causative role for HSV in this highly selected group of patients. |
---|---|
Mesh-Begriff(e) | Acyclovir/therapeutic use ; Aged ; Antiviral Agents/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Pneumonia, Ventilator-Associated/epidemiology ; Pneumonia, Ventilator-Associated/mortality ; Radiography/methods ; Retrospective Studies ; Simplexvirus/drug effects ; Simplexvirus/pathogenicity ; Statistics, Nonparametric ; Survival Analysis ; Tomography, X-Ray Computed/methods |
Chemische Substanzen | Antiviral Agents ; Acyclovir (X4HES1O11F) |
Schlagwörter | covid19 |
Sprache | Englisch |
Erscheinungsdatum | 2020-01-10 |
Erscheinungsland | England |
Dokumenttyp | Journal Article |
ZDB-ID | 2041406-7 |
ISSN | 1466-609X ; 1364-8535 |
ISSN (online) | 1466-609X |
ISSN | 1364-8535 |
DOI | 10.1186/s13054-019-2701-5 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 5517: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.